Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Macular Edema Secondary to Branch Retinal Vein Occlusion”

30 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 30 results

Post-approval studies (Phase 4)Ended earlyNCT01795209
What this trial is testing

Ranibizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion in Patients With Fair Vision

Who this might be right for
Branch Retinal Vein OcclusionMacular Edema
Seoul National University Bundang Hospital 19
Testing effectiveness (Phase 2)Study completedNCT04667897
What this trial is testing

601 Versus Ranibizumab in Patients With Branch Retinal Vein Occlusion (BRVO)

Who this might be right for
Branch Retinal Vein Occlusion
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 60
Not applicableStudy completedNCT02556723
What this trial is testing

Intravitreal Injections of Ziv-aflibercept for Macular Diseases

Who this might be right for
Diabetic Macular EdemaAge Related Macular DegenerationBranch Retinal Vein Occlusion With Macular Edema+1 more
Retina Clinic, Sao Paulo, Brazil 60
Large-scale testing (Phase 3)Ended earlyNCT03810313
What this trial is testing

Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion

Who this might be right for
Central Retinal Vein Occlusion
Novartis Pharmaceuticals 493
Large-scale testing (Phase 3)Study completedNCT01976338
What this trial is testing

Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Branch Retinal Vein Occlusion (BRVO)

Who this might be right for
Macular Edema Secondary to Branch Retinal Vein Occlusion
Novartis Pharmaceuticals 283
Not applicableStudy completedNCT01614509
What this trial is testing

Combined Therapy of Posterior Subtenon Triamcinolone Acetonide and Intravitreal Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion

Who this might be right for
Branch Retinal Vein Occlusion
Yeungnam University College of Medicine 45
Large-scale testing (Phase 3)Study completedNCT04592419
What this trial is testing

Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Patients With Macular Edema Due to Retinal Vein Occlusion (RVO)

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Kodiak Sciences Inc 568
Not applicableStudy completedNCT03054766
What this trial is testing

Combination of Intravitreal Ranibizumab With or Without Macular Laser Photocoagulation for ME Secondary to BRVO

Who this might be right for
Branch Retinal Vein OcclusionRanibizumabLaser Photocoagulation
Beijing Hospital 80
Large-scale testing (Phase 3)Study completedNCT04740905
What this trial is testing

Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branch Retinal Vein Occlusion

Who this might be right for
Macular EdemaBranch Retinal Vein Occlusion
Hoffmann-La Roche 553
Post-approval studies (Phase 4)Study completedNCT00406107
What this trial is testing

Evaluation of Macugen Treatment of Macular Edema Due to Branch Retinal Vein Occlusion

Who this might be right for
Branch Retinal Vein Occlusion
Palmetto Retina Center, LLC 20
Testing effectiveness (Phase 2)Study completedNCT01968239
What this trial is testing

Proof of Concept Study of Re-treatment in BRVO With Ranibizumab Guided by OCT

Who this might be right for
Branch Retinal Vein Occlusion
University of Leipzig 27
Not applicableStudy completedNCT00562406
What this trial is testing

Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES)

Who this might be right for
Macular Edema
Klinikum Ludwigshafen 30
Post-approval studies (Phase 4)Study completedNCT02800642
What this trial is testing

Evaluation of a Treat and Extend Regimen of Intravitreal Aflibercept for Macular Edema Secondary to CRVO

Who this might be right for
Central Retinal Vein Occlusion
Bayer 162
Large-scale testing (Phase 3)Study completedNCT05520177
What this trial is testing

A Phase III Study for 601 Versus Ranibizumab in Patients With Vision Loss

Who this might be right for
Branch Retinal Vein Occlusion
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 351
Testing effectiveness (Phase 2)UnknownNCT01809236
What this trial is testing

Efficacy and Safety of Conbercept in Macular Edema Secondary to Retinal Vein Occlusion

Who this might be right for
Retinal Vein Occlusion
Chengdu Kanghong Biotech Co., Ltd. 60
Not applicableStudy completedNCT04137120
What this trial is testing

Study to Gather Information on the Safety and Use of Aflibercept Injections Into the Eye for the Treatment of Eye Disorders in Mexican Routine Clinical Practice

Who this might be right for
Retinal Disease
Bayer 73
Testing effectiveness (Phase 2)Study completedNCT02614937
What this trial is testing

Study of Squalamine Lactate for the Treatment of Macular Edema Related to Retinal Vein Occlusion

Who this might be right for
Retinal Vein OcclusionMacular Edema
Ohr Pharmaceutical Inc. 20
Not applicableStudy completedNCT01219205
What this trial is testing

Major and Macular Branched Retinal Venous Occlusion

Who this might be right for
Macular Edema
Hallym University Medical Center 46
Large-scale testing (Phase 3)Study completedNCT01377597
What this trial is testing

Efficacy and Safety of Ranibizumab in Japanese Patients With Retinal Vein Occlusion

Who this might be right for
Retinal Vein Occlusion
Novartis Pharmaceuticals 47
Large-scale testing (Phase 3)Ended earlyNCT03802630
What this trial is testing

Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Branch Retinal Vein Occlusion

Who this might be right for
Branch Retinal Vein Occlusion
Novartis Pharmaceuticals 450
Load More Results